Partnership aims to improve preclinical liver toxicity testing methods

详细信息    查看全文

• 刊名：Membrane Technology
• 出版年：May 2014
• 年：2014
• 卷：2014
• 期：5
• 页码：6
• 全文大小：62 K

文摘

EMD Millipore, the life sciences division of Merck KGaA, Darmstadt, Germany, recently received a grant of $400 000 from the US-based Massachusetts Life Sciences Center (MLSC) to fund a partnership with Promethera Biosciences Sa/Nv, a Belgian pharmaceuticals company that focuses on developing and commercialising cell therapy products to treat liver diseases in an innovative way.